In agreement of the report that TMEM25 is a favorable marker for survival of breast cancer patient22, analysis using UCSC Xena platform (https://xena.ucsc.edu) showed a statistically significant difference of survival rates in breast cancer patients with relatively high and low expression of TMEM25 (Supplementary Fig. 2d). This evidence concerns the gene TMEM25 and breast carcinoma.